These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 37758275)

  • 21. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.
    Stock CJ; Sato H; Fonseca C; Banya WA; Molyneaux PL; Adamali H; Russell AM; Denton CP; Abraham DJ; Hansell DM; Nicholson AG; Maher TM; Wells AU; Lindahl GE; Renzoni EA
    Thorax; 2013 May; 68(5):436-41. PubMed ID: 23321605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nintedanib in Progressive Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.
    Ghazipura M; Mammen MJ; Herman DD; Hon SM; Bissell BD; Macrea M; Kheir F; Khor YH; Knight SL; Raghu G; Wilson KC; Hossain T
    Ann Am Thorac Soc; 2022 Jun; 19(6):1040-1049. PubMed ID: 35499854
    [No Abstract]   [Full Text] [Related]  

  • 23. Sarcoidosis and interstitial pulmonary fibrosis; two distinct disorders or two ends of the same spectrum.
    Shigemitsu H; Azuma A
    Curr Opin Pulm Med; 2011 Sep; 17(5):303-7. PubMed ID: 21681100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases.
    Prior C; Haslam PL
    Clin Exp Immunol; 1992 May; 88(2):280-7. PubMed ID: 1572093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and Management of Fibrotic Interstitial Lung Diseases.
    Collins BF; Luppi F
    Clin Chest Med; 2021 Jun; 42(2):321-335. PubMed ID: 34024407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity of pulmonary fibrosis: interstitial pneumonias and sarcoidosis.
    Nagai S; Nagao T; Hoshino Y; Hamada K
    Curr Opin Pulm Med; 2001 Sep; 7(5):262-71. PubMed ID: 11584174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities.
    George PM; Spagnolo P; Kreuter M; Altinisik G; Bonifazi M; Martinez FJ; Molyneaux PL; Renzoni EA; Richeldi L; Tomassetti S; Valenzuela C; Vancheri C; Varone F; Cottin V; Costabel U;
    Lancet Respir Med; 2020 Sep; 8(9):925-934. PubMed ID: 32890499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current perspective of progressive-fibrosing interstitial lung disease.
    Kishaba T
    Respir Investig; 2022 Jul; 60(4):503-509. PubMed ID: 35431170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
    Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
    Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence of lung granulomas in patients with stage I sarcoidosis.
    Rosen Y; Amorosa JK; Moon S; Cohen J; Lyons HA
    AJR Am J Roentgenol; 1977 Dec; 129(6):1083-5. PubMed ID: 413363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An autopsy case of sarcoidosis followed up for 27 years, with special reference to pulmonary fibrosis.
    Takemura T; Eishi Y; Matsui Y
    Acta Pathol Jpn; 1988 Jul; 38(7):909-20. PubMed ID: 2847479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sarcoidosis-associated pulmonary hypertension: assessment and management.
    Palmero V; Sulica R
    Semin Respir Crit Care Med; 2010 Aug; 31(4):494-500. PubMed ID: 20665399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies for identifying pulmonary sarcoidosis patients at risk for severe or chronic disease.
    Judson MA
    Expert Rev Respir Med; 2017 Feb; 11(2):111-118. PubMed ID: 28076979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency of acute worsening events in fibrotic pulmonary sarcoidosis patients.
    Baughman RP; Lower EE
    Respir Med; 2013 Dec; 107(12):2009-13. PubMed ID: 24211131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
    Behr J; Prasse A; Kreuter M; Johow J; Rabe KF; Bonella F; Bonnet R; Grohe C; Held M; Wilkens H; Hammerl P; Koschel D; Blaas S; Wirtz H; Ficker JH; Neumeister W; Schönfeld N; Claussen M; Kneidinger N; Frankenberger M; Hummler S; Kahn N; Tello S; Freise J; Welte T; Neuser P; Günther A;
    Lancet Respir Med; 2021 May; 9(5):476-486. PubMed ID: 33798455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Mechanism in the Development of Pulmonary Fibrosis in Patients with Sarcoidosis.
    Cocconcelli E; Bernardinello N; Castelli G; Petrarulo S; Bellani S; Saetta M; Spagnolo P; Balestro E
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases.
    Cottin V; Richeldi L; Rosas I; Otaola M; Song JW; Tomassetti S; Wijsenbeek M; Schmitz M; Coeck C; Stowasser S; Schlenker-Herceg R; Kolb M;
    Respir Res; 2021 Mar; 22(1):84. PubMed ID: 33726766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in rheumatoid arthritis-associated interstitial lung disease.
    Juge PA; Crestani B; Dieudé P
    Curr Opin Pulm Med; 2020 Sep; 26(5):477-486. PubMed ID: 32701675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis.
    Finnerty JP; Ponnuswamy A; Dutta P; Abdelaziz A; Kamil H
    BMC Pulm Med; 2021 Dec; 21(1):411. PubMed ID: 34895203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis.
    Schimmelpennink MC; Meek DB; Vorselaars ADM; Langezaal LCM; van Moorsel CHM; van der Vis JJ; Veltkamp M; Grutters JC
    Respir Res; 2022 Jun; 23(1):169. PubMed ID: 35752806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.